BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23045537)

  • 1. Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population.
    Raich PC; Whitley EM; Thorland W; Valverde P; Fairclough D;
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1629-38. PubMed ID: 23045537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program.
    Markossian TW; Darnell JS; Calhoun EA
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1691-700. PubMed ID: 23045544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of patient navigation on timely cancer care: the Patient Navigation Research Program.
    Freund KM; Battaglia TA; Calhoun E; Darnell JS; Dudley DJ; Fiscella K; Hare ML; LaVerda N; Lee JH; Levine P; Murray DM; Patierno SR; Raich PC; Roetzheim RG; Simon M; Snyder FR; Warren-Mears V; Whitley EM; Winters P; Young GS; Paskett ED;
    J Natl Cancer Inst; 2014 Jun; 106(6):dju115. PubMed ID: 24938303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Navigation for Comprehensive Cancer Screening in High-Risk Patients Using a Population-Based Health Information Technology System: A Randomized Clinical Trial.
    Percac-Lima S; Ashburner JM; Zai AH; Chang Y; Oo SA; Guimaraes E; Atlas SJ
    JAMA Intern Med; 2016 Jul; 176(7):930-7. PubMed ID: 27273602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.
    Ramachandran A; Snyder FR; Katz ML; Darnell JS; Dudley DJ; Patierno SR; Sanders MR; Valverde PA; Simon MA; Warren-Mears V; Battaglia TA;
    Cancer; 2015 Nov; 121(22):4016-24. PubMed ID: 26385420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Different Intensities of Patient Navigation After Abnormal Mammography.
    Glassgow AE; Molina Y; Kim S; Campbell RT; Darnell J; Calhoun EA
    Health Promot Pract; 2019 Nov; 20(6):914-921. PubMed ID: 29907079
    [No Abstract]   [Full Text] [Related]  

  • 7. A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities.
    Wells KJ; Lee JH; Calcano ER; Meade CD; Rivera M; Fulp WJ; Roetzheim RG
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1664-72. PubMed ID: 23045541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening.
    Battaglia TA; Bak SM; Heeren T; Chen CA; Kalish R; Tringale S; Taylor JO; Lottero B; Egan AP; Thakrar N; Freund KM
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1645-54. PubMed ID: 23045539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests?
    Paskett ED; Katz ML; Post DM; Pennell ML; Young GS; Seiber EE; Harrop JP; DeGraffinreid CR; Tatum CM; Dean JA; Murray DM;
    Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1620-8. PubMed ID: 23045536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL.
    Lee JH; Fulp W; Wells KJ; Meade CD; Calcano E; Roetzheim R
    PLoS One; 2013; 8(9):e74542. PubMed ID: 24066145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of patient navigation on the delivery of diagnostic breast cancer care in the National Patient Navigation Research Program: a prospective meta-analysis.
    Battaglia TA; Darnell JS; Ko N; Snyder F; Paskett ED; Wells KJ; Whitley EM; Griggs JJ; Karnad A; Young H; Warren-Mears V; Simon MA; Calhoun E
    Breast Cancer Res Treat; 2016 Aug; 158(3):523-34. PubMed ID: 27432417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital.
    Nonzee NJ; McKoy JM; Rademaker AW; Byer P; Luu TH; Liu D; Richey EA; Samaras AT; Panucci G; Dong X; Simon MA
    BMC Health Serv Res; 2012 Sep; 12():340. PubMed ID: 23009152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Navigation Improves Subsequent Breast Cancer Screening After a Noncancerous Result: Evidence from the Patient Navigation in Medically Underserved Areas Study.
    Molina Y; Kim SJ; Berrios N; Glassgow AE; San Miguel Y; Darnell JS; Pauls H; Vijayasiri G; Warnecke RB; Calhoun EA
    J Womens Health (Larchmt); 2018 Mar; 27(3):317-323. PubMed ID: 28933653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Navigating veterans with an abnormal prostate cancer screening test: a quasi-experimental study.
    Simon MA; Nonzee NJ; McKoy JM; Liu D; Luu TH; Byer P; Eklund EA; Richey EA; Wu Z; Dong X; Rademaker AW
    BMC Health Serv Res; 2013 Aug; 13():314. PubMed ID: 23947435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program.
    Bensink ME; Ramsey SD; Battaglia T; Fiscella K; Hurd TC; McKoy JM; Patierno SR; Raich PC; Seiber EE; Warren-Mears V; Whitley E; Paskett ED; Mandelblatt S;
    Cancer; 2014 Feb; 120(4):570-8. PubMed ID: 24166217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Navigation in Medically Underserved Areas study design: A trial with implications for efficacy, effect modification, and full continuum assessment.
    Molina Y; Glassgow AE; Kim SJ; Berrios NM; Pauls H; Watson KS; Darnell JS; Calhoun EA
    Contemp Clin Trials; 2017 Feb; 53():29-35. PubMed ID: 27940186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining the Patient Navigation Role in a Colorectal Cancer Screening Program: Results From an Intervention Study.
    Rohan EA; Slotman B; DeGroff A; Morrissey KG; Murillo J; Schroy P
    J Natl Compr Canc Netw; 2016 Nov; 14(11):1371-1378. PubMed ID: 27799508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social service barriers delay care among women with abnormal cancer screening.
    Primeau SW; Freund KM; Ramachandran A; Bak SM; Heeren T; Chen CA; Morton S; Battaglia TA
    J Gen Intern Med; 2014 Jan; 29(1):169-75. PubMed ID: 24197626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of an integrated framework for a breast cancer screening and navigation program for women from underresourced communities.
    Henderson V; Tossas-Milligan K; Martinez E; Williams B; Torres P; Mannan N; Green L; Thompson B; Winn R; Watson KS
    Cancer; 2020 May; 126 Suppl 10():2481-2493. PubMed ID: 32348565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of comorbidities and patient navigation with the time to diagnostic resolution after abnormal cancer screening.
    Whitley EM; Raich PC; Dudley DJ; Freund KM; Paskett ED; Patierno SR; Simon M; Warren-Mears V; Snyder FR;
    Cancer; 2017 Jan; 123(2):312-318. PubMed ID: 27648520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.